Loading...
Novartis Community
SWX:NOVN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 142 Fair Values set on narratives written by author
Community Investing Ideas
NOVN: Future Trial Data And Pipeline Advancements Will Support Steady Returns
Key Takeaways Strong demand for innovative therapies and expansion in emerging markets support growth, while operational efficiency boosts margins and long-term profitability. Advancements in advanced therapies and substantial shareholder returns position the company for accelerated earnings and enhanced equity performance.Read more
1users have liked this narrative
0users have commented on this narrative
84users have followed this narrative
AN
CHF 102.12
0.6% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
3.29% p.a.
Profit Margin
29.4%
Future PE
13.19x
Share price in 2028
CHF 114.24